TIOGIVA

This brand name is authorized in Austria, Finland, Ireland, United Kingdom

Active ingredients

The drug TIOGIVA contains one active pharmaceutical ingredient (API):

1 Tiotropium
UNII XX112XZP0J - TIOTROPIUM BROMIDE ANHYDROUS

Tiotropium is a long-acting, specific, muscarinic receptor antagonist, in clinical medicine often called an anticholinergic. By binding to the muscarinic receptors in the bronchial smooth musculature, tiotropium inhibits the cholinergic (bronchoconstrictive) effects of acetylcholine, released from parasympathetic nerve endings.

Read about Tiotropium

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
TIOGIVA Inhalation powder, hard capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03BB04 Tiotropium bromide R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics
Discover more medicines within R03BB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FI Lรครคkealan turvallisuus- ja kehittรคmiskeskus Identifier(s): 153420, 413829, 510482
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 396058, 396073, 396075

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.